<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Recurrent Herpes Labialis: Developing Drugs for Treatment and Prevention; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Recurrent Herpes Labialis: Developing Drugs for Treatment and Prevention; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2016-07-01 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Recurrent Herpes Labialis: Developing Drugs for Treatment and Prevention." The purpose of this guidance is to assist sponsors in all phases of development of treatments for recurrent herpes labialis. The guidance also addresses prevention of recurrent herpes labialis. The guidance outlines the types of nonclinical studies and clinical trials recommended throughout the drug d...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2016-15698</p>
    <p><strong>Publication Date:</strong> 2016-07-01</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2016/07/01/2016-15698/recurrent-herpes-labialis-developing-drugs-for-treatment-and-prevention-draft-guidance-for-industry">https://www.federalregister.gov/documents/2016/07/01/2016-15698/recurrent-herpes-labialis-developing-drugs-for-treatment-and-prevention-draft-guidance-for-industry</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2016-15698</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
